External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: A multi-institutional outcome analysis

Japanese Journal of Clinical Oncology

Volumn 38, Issue 3, 2008, Pages 200-204

  Nakamura, Katsumasa ^a   Mizowaki, Takashi ^b   Imada, Hajime ^c   Karasawa, Katsuyuki ^d   Uno, Takashi ^e   Onishi, Hiroshi ^f   Nihei, Keiji ^g   Sasaki, Shigeru ^h   Ogura, Masakazu ⁱ   Akimoto, Tetsuo ^j  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f UNIVERSITY OF YAMANASHI   (Japan)

^g NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^h SHINSHU UNIVERSITY   (Japan)

ⁱ TENRI HOSPITAL   (Japan)

^j TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Prostatic neoplasms; Radiotherapy; Treatment outcome

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; COMORBIDITY; GASTROINTESTINAL HEMORRHAGE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; SURVIVAL RATE; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; COMORBIDITY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; JAPAN; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 40749129303     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn008     Document Type: Article

References (17)

1. Pu YS, Chiang HS, Lin CC, Huang CY, Huang KH, Chen J. Changing trends of prostate cancer in Asia. Aging Male 2004;7:120-32.
2. Marugame T, Mizuno S. Comparison of prostate cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol 2005;35:690-1.
3. Watanabe H. Mass screening program for prostatic cancer in Japan. Int J Clin Oncol 2001;6:66-73.
4. Akaza H, Moore MA, Chang SJ, Cheng C, Choi HY, Esuvaranathan K, et al. The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy. Asian Pac J Cancer Prev 2007;8:3-12.
5. Nakamura K, Ogawa K, Yamamoto T, Sasaki T, Koizumi M, Teshima T, et al. Trends in the practice of radiotherapy for localized prostate cancer in Japan: A preliminary patterns of care study report. Jpn J Clin Oncol 2003;33:527-32.
6. Ogawa K, Nakamura K, Onishi H, Sasaki T, Koizumi M, Shioyama Y, et al. Radical external beam radiotherapy for prostate cancer in Japan: Results of the 1999-2001 patterns of care process survey. Jpn J Clin Oncol 2006;36:40-5.
7. Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, et al. Radical radiation therapy for prostate cancer in Japan: A patterns of care study report. Jpn J Clin Oncol 2003;33:122-6.
8. Mitsumori M, Sasaki Y, Mizowaki T, Takayama K, Nagata Y, Hiraoka M et al. Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: Comparison of two different definitions of PSA failure. Int J Clin Oncol 2006;11:396-402.
9. Sobin LH, Wittekind C, editors. TNM classification of Malignant tumours. 6th edn. New York: Wiley Liss 2002.
10. Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:380-5.
11. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37:1035-41.
12. Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, et al. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: A multi-institutional outcome study in Japan. BJU Int 2006;98:549-53.
13. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations af the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965-74.
14. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 2002;360:103-6.
15. Takahashi S. Conformation radiotherapy, rotation techniques as applied to radiography. Acta Radiol Suppl 1965;242:1-142.
16. Nakano T. Status of Japanese radiation oncology. Radiat Med 2004;22:17-9.
17. Lawton CA, DeSilvio M, Roach M 3rd, Uhl V, kirsch R, Seider M, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/ radiation interactions. Int J Radiat Oncol Biol Phys 2007;69:646-55.